fashion -WSS

fashion

author：knowledge 2025-09-05 05:49:42 - browse：78

health care AI border between health care and tech — Adobe

There’s been significant investment in companies creating artificial intelligence (AI) applications for health and health care over the last decade. But while there have been successes, notably in the area of medical imaging, the industry is known more for not yet living up to its potential — think IBM Watson.

The slow pace of AI adoption in health care stems from the fact that health AI sits on the border between two large industries, health care and tech. And like the border between two nations, there are significant differences on either side.

During my career, I have spent time on each side. Now, as the CEO of a company on the border, I’ve developed a deeper understanding of the differences that create barriers to mutual innovation. For health AI to achieve its potential, health care and tech companies must keep the big picture top of mind: health care is about saving lives.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Flu, Covid vaccination rates decline, new survey data show

focus

WSS

Too many hospitalized Covid

Setback for rare diseases as Taysha Gene Therapies pulls back

Having children helps parents live longer, especially after age 80

Eli Lilly reports tirzepatide MASH success during Q4 earnings

New oral drug delivery patch is modeled after octopus tentacles

Why Eli Lilly’s earnings didn’t quite live up to the hype

knowledge

fashion

explore

Peter Hotez and the public health issue of online harassment

Artificial intelligence use in health care faces greater scrutiny in 2024

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Congress considering partial increase for doctor pay in Medicare

Psychedelics group wrestles with new pharma identity

Stop Congress from blocking public access to science

Supreme Court strikes down use of affirmative action

Lawsuit highlights wrinkle for disputes over surprise medical bills

Alkermes shareholders re

Report cites 'urgent' need to recruit more diverse clinical trial participants

focus

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

CDC picks Alphabet's Verily for wasterwater surveillance contract

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

The Karikó problem: Lessons for funding basic research

6 solutions to address cancer drug shortages and others

Some top drug companies are starting to take action on climate

focus

focus

hotspot

hotspot